![[Feedback]](/icons/banner/feedbackACT.gif)
![[For Subscribers]](/icons/banner/subscriberACT.gif)
![[Archive]](/icons/banner/archiveACT.gif)
![[Search]](/icons/banner/searchACT.gif)
![[Contents]](/icons/banner/tocACT.gif)
Previous Article | Next Article 
Journal of Virology, September 1999, p. 7866-7869, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Turnover of T Cells in Murine Gammaherpesvirus
68-Infected Mice
Ann Marie
Hamilton-Easton,
Jan P.
Christensen, and
Peter
C.
Doherty*
Department of Immunology, St. Jude
Children's Research Hospital, Memphis, Tennessee
Received 1 February 1999/Accepted 15 June 1999
 |
ABSTRACT |
Respiratory challenge of C57BL/6 mice with murine gammaherpesvirus
68 induces proliferation of T lymphocytes early after infection, as
evidenced by incorporation of the DNA precursor bromodeoxyuridine. Using pulse-chase analysis, splenic and peripheral blood activated T
lymphocytes were found to continue dividing for at least a month after
the initial virus challenge. The results are in accord with the idea
that T cells are stimulated for a substantial time after the acute,
lytic phase of virus infection is resolved.
| |
TEXT |
Intranasal infection of mice with
murine gammaherpesvirus 68 (MHV-68) leads to productive infection of
the respiratory epithelium which is controlled by CD8+ T
lymphocytes within 10 to 13 days of the initial exposure (3, 6) and establishes a persistent, latent infection in B
lymphocytes (12, 17, 18). The infected mice show marked
splenomegaly within 14 to 18 days of challenge (16),
developing a blood picture similar (15) to that associated
with Epstein-Barr virus-induced infectious mononucleosis (IM) of
humans. Proliferating splenic lymphoid cells have been detected in mice
as early as 3 to 5 days after infection and continue to be evident
during the onset of IM (5, 15). Similar to the blood picture
of Epstein-Barr virus-infected adolescents (9, 10), the
IM-like phase is characterized by increased numbers of activated T
lymphocytes in the blood of MHV-68-infected mice for at least 2 months
after infection (15). Although activated CD8+ T
cells are more prominent, the effect is also apparent for the CD4+ set. The general impression is that the massive
proliferation of lymphoid cells in the spleen leads to the IM-like
syndrome in the peripheral blood.
A central question is whether the protracted presence of activated
lymphoid cells in the blood reflects continued proliferation or
accumulation. The extent of proliferation was addressed by giving
MHV-68-infected mice drinking water containing a DNA precursor, bromodeoxyuridine (BrdU). Following a pulse-labeling period, the various lymphocyte subsets were stained for expression of surface markers and BrdU in accordance with published methods (2,
14). The results confirm the earlier impression, generated by
staining for cellular DNA with propidium iodide, that splenic T
lymphocytes begin to proliferate early after infection and continue
throughout the later IM-like phase of this disease process (5,
15). The blood picture mimics that seen in the spleen, indicating
that activated lymphoid cells multiply for several weeks following the
initial encounter with MHV-68.
Characterization of cell proliferation with
BrdU.
Female C57BL/6J (B6) mice,
purchased from The Jackson Laboratory (Bar Harbor, Maine) were infected
with MHV-68 at 6 to 10 weeks of age as previously described
(15). Groups of MHV-68-infected B6 mice were given drinking
water containing BrdU (Sigma Chemical Co., St. Louis, Mo.) at 0.8 mg/ml, which was made fresh and changed every day. The protocol for the
pulse-labeling studies was that mice were given BrdU for 6 days
prior to analysis and then the turnover rate of lymphoid cells was
evaluated by analyzing for the disappearance of the BrdU-labeled cells
through a chase period after withdrawal of the water containing BrdU.
This BrdU feeding protocol (14) is sufficient to label
>95% of CD4+8+ thymocytes (data not shown).
At various times after infection, peripheral blood cells and spleens
were taken and the cell phenotypes and activation status were
determined by flow cytometric methods described elsewhere
(15). Lymphocytes were then analyzed for BrdU incorporation
in accordance with published methods (14).
View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Representation of the method used to determine BrdU
expression in a given population of cells. After a 6-day pulse with
BrdU-containing drinking water, single-cell suspensions of spleens from
MHV-68-infected mice were stained for flow cytometric analysis using a
phycoerythrin-conjugated anti-CD8 antibody (53-6.72; Pharmingen, San
Diego, Calif.), a biotin-conjugated anti-CD62L antibody (MEL-14;
Pharmingen), streptavidin-conjugated RED670 (Becton Dickinson, San
Jose, Calif.), and a fluorescein isothiocyanate-conjugated anti-BrdU
antibody (Becton Dickinson). (A) Gates were set around the activated
(CD8+ CD62Llo) and resting (CD8+
CD62Lhi) populations based on surface expression, and (B
and C) histograms showing BrdU expression were drawn for each
population. Based on these histograms, BrdU expression was separated
into low, intermediate, and high groups and percentages of all three
were determined.
|
|
Using cells obtained after a 6-day pulse, gates were set around the
population of choice to obtain the percentage of BrdU incorporation
(Fig. 1A, CD8+ CD62Llo versus CD8+
CD62Lhi). A histogram of BrdU expression was then plotted
for the delineated set (Fig. 1B versus C), and the BrdU expression
profile was characterized as low, intermediate, or high; this
convention was used throughout. However, for clarity, only the
percentages of cells incorporating high levels of BrdU are shown in the
data that follow.
Correlation of T-cell proliferation with activation status.
High levels of CD44 expression or low levels of CD62L identify
activated T lymphocytes (1, 7, 8, 11). Those T lymphocytes with an "activated" phenotype (CD44hi or
CD62Llo) showed much greater levels of BrdU incorporation
(Fig. 2) than those with the
characteristics of naive (CD62Lhi) or resting
(CD44lo) cells.
View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Either CD44 or CD62L expression can be used to monitor
BrdU incorporation in activated-T-cell populations. Mice were infected
with MHV-68 and given drinking water containing BrdU for 6 days prior
to days 0, 9, 15, 21, and 33 after infection, when spleens were removed
and single-cell suspensions were stained. The anti-CD44-biotin
monoclonal antibody (IM7) was obtained from Pharmingen. After the 6-day
pulse, BrdU was removed from the drinking water of the remaining mice
and the analysis was repeated at various times during the chase period.
The top two panels show the BrdU staining profiles for CD8+
T cells using CD44 as a measurement of activation. The lower two panels
characterize the same population of CD8+ T cells using
CD62L for the same purpose. The percentages of cells expressing low,
intermediate, and high levels of BrdU are shown in each panel. The
lymphocytes were analyzed from pools of three or four mice.
|
|
Kinetic analysis of both spleens and peripheral blood lymphocytes
established that the CD4+ CD44hi (Fig.
3) sets began proliferating as early as
day 9 after infection. This is in accord with the observation that
virus-specific CD4+ T cells can be detected early in the
course of this infectious process by ELISpot analysis of mediastinal
lymph nodes (4). These CD4+ T lymphocytes
continued to turn over for at least a month after MHV-68 infection. The
high levels of proliferation found for activated CD4+ T
cells were also reflected in increased total counts for the CD4+ CD44hi cells in the spleen, with maximal
numbers being found at days 15 and 21 after infection (Fig.
4).
View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
BrdU incorporation into CD4+ T cells from
the spleens and peripheral blood of MHV-68-infected mice. B6 mice were
infected with MHV-68 and given BrdU as described in the legend to Fig.
2. Flow cytometric analysis was performed as described in the legend to
Fig. 1, with the exception that cells were stained with antibodies to
the CD4 (phycoerythrin-conjugated anti-CD4 antibody RM4-5; Pharmingen)
and CD44 surface proteins. The percentages of CD4+
CD44hi cells that incorporated high levels of BrdU during a
6-day pulse (open squares) and during subsequent chase periods (closed
squares) are depicted for the spleen (A) and peripheral blood (C).
Percentages of resting CD4+ T cells, those depicted in the
CD44lo population, that express high levels of BrdU are
similarly depicted for the spleen (B) and peripheral blood (D). Cells
were pooled from three or four mice.
|
|
View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Total numbers of proliferating activated T cells in the
spleens of MHV-68-infected mice. The total numbers of CD8+
CD44hi and CD4+ CD44hi cells
incorporating BrdU during a 6-day pulse were determined based on the
percentages of cells incorporating BrdU within the aforementioned cell
populations and the total spleen cell number (using standard
hemacytometer and trypan blue exclusion tests). Each time point
represents a pool of three or four mice.
|
|
The level of proliferation appears to be greatest during the IM-like
stage of the infection. During this time, there is also marked turnover
of CD4+ CD44lo cells in the peripheral blood.
It is conceivable that these cells begin proliferating prior to
increasing their levels of expression of CD44. If, indeed, at least
some of the increase in activated T cells during this time is cytokine
driven, it is possible that cytokines might also promote the
"bystander" proliferation of antigen nonspecific cells without a
concurrent switch in the activation phenotype (13).
Alternatively, there is such a high degree of turnover in the spleen at
this time that trafficking of cells into and out of this and other
peripheral lymphoid organs could account for the apparent increase in
the level of proliferation of nonactivated CD4+ T
lymphocytes in the peripheral blood.
Similar to the activated CD4+ T lymphocytes, proliferation
of splenic CD8+ CD44hi cells also began early
after mice were infected with MHV-68 and continued for several weeks
(Fig. 5). This finding was also reflected in increased total counts for the activated CD8+ T
lymphocytes in the spleen (Fig. 4). The proliferative activity in the
peripheral blood lymphocytes was generally reflective of that in the
spleen, although the result seen during the chase on day 25 could be
thought to reflect an increased rate of export of proliferating T cells
from the spleen. During the IM-like stage of the infection, there
appear to be higher percentages of proliferating CD8+
cells, both CD44lo and CD44hi, in the
peripheral blood. It is known that there is considerable expansion of
CD8+ V
4+ cells at this time (15).
What is not understood is the cell loss in this population. A high
level of cell death, possibly due to the apoptosis of CD8+
T cells with exhausted proliferative potential that did not incorporate BrdU during the previous pulse period, could account for the relative increase in proliferating CD8+ cells on days 25 and 29 compared to day 21.
View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
BrdU incorporation into CD8+ T cells from
the spleens and peripheral blood of MHV-68-infected mice. Mice were
infected with MHV-68 and given BrdU as described in the legend to Fig.
2. Flow cytometric analysis was performed as described in the legend to
Fig. 1, with the exception that cells were stained with antibodies to
the CD8 and CD44 surface proteins. The percentages of CD8+
CD44hi cells that incorporated high levels of BrdU during a
6-day pulse (open squares) and during subsequent chase periods (closed
squares) are depicted for the spleen (A) and peripheral blood (C).
Percentages of resting CD8+ T cells, those depicted in the
CD44lo population, that express high levels of BrdU are
similarly depicted for the spleen (B) and peripheral blood (D). Cells
were pooled from the spleens and peripheral blood of three or four mice
for analysis.
|
|
In conclusion, results from this study indicate that there are
significant changes in population dynamics during MHV-68 infection. Activated T lymphocytes undergo enormous proliferation for at least the
first month after infection. Evaluation of the levels of cell death due
to apoptosis within these populations would add to the overall picture
of cell turnover and population dynamics associated with MHV-68 infection.
| |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grants CA21765 and
AI38359 and by the American Lebanese-Syrian Associated Charities (ALSAC).
| |
FOOTNOTES |
*
Corresponding author. Mailing address: St. Jude
Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105. Phone: (901) 495-3470. Fax: (901) 495-3107. E-mail:
peter.doherty{at}stjude.org.
| |
REFERENCES |
| 1.
|
Budd, R. C.,
J.-C. Cerottini,
C. Horvath,
C. Bron,
T. Pedrazzini,
R. C. Howe, and H. R. MacDonald.
1987.
Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation.
J. Immunol.
138:3120-3129[Abstract].
|
| 2.
|
Carayon, P., and A. Bord.
1992.
Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA.
J. Immunol. Methods
147:225-230[Medline].
|
| 3.
|
Cardin, R. D.,
J. W. Brooks,
S. R. Sarawar, and P. C. Doherty.
1996.
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
J. Exp. Med.
184:863-871[Abstract/Free Full Text].
|
| 4.
|
Christensen, J. P., and P. C. Doherty.
1999.
Quantitative analysis of the acute and long-term CD4+ T-cell response to a persistent gammaherpesvirus.
J. Virol.
73:4279-4283[Abstract/Free Full Text].
|
| 5.
|
Doherty, P. C.,
R. A. Tripp,
A. M. Hamilton-Easton,
R. D. Cardin,
D. L. Woodland, and M. A. Blackman.
1997.
Tuning into immunological dissonance: an experimental model for infectious mononucleosis.
Curr. Opin. Immunol.
9:477-483[Medline].
|
| 6.
|
Ehtisham, S.,
N. P. Sunil-Chandra, and A. A. Nash.
1993.
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells.
J. Virol.
67:5247-5252[Abstract/Free Full Text].
|
| 7.
|
Jung, T. M.,
W. M. Gallatin,
I. L. Weissman, and M. O. Dailey.
1988.
Down-regulation of homing receptors after T cell activation.
J. Immunol.
141:4110-4117[Abstract].
|
| 8.
|
MacDonald, H. R.,
R. C. Budd, and J.-C. Cerottini.
1990.
Pgp-1 (Ly24) as a marker of murine memory T lymphocytes.
Curr. Top. Microbiol. Immunol.
159:97-109[Medline].
|
| 9.
|
Miyawaki, T.,
Y. Kasahara,
H. Kanegane,
K. Ohta,
T. Yokoi,
A. Yachie, and N. Taniguchi.
1991.
Expression of CD45RO (UCHL1) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis.
Clin. Exp. Immunol.
83:447-451[Medline].
|
| 10.
|
Reynolds, D. J.,
P. M. Banks, and M. L. Gulley.
1995.
New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
Am. J. Pathol.
146:379-388[Abstract].
|
| 11.
|
Sprent, J., and D. F. Tough.
1994.
Lymphocyte life-span and memory.
Science
265:1395-1400[Abstract/Free Full Text].
|
| 12.
|
Sunil-Chandra, N. P.,
S. Efstathiou, and A. A. Nash.
1992.
Murine  -herpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.
J. Gen. Virol.
73:3275-3279[Abstract/Free Full Text].
|
| 13.
|
Tough, D. F.,
P. Borrow, and J. Sprent.
1996.
Induction of bystander T cell proliferation by viruses and type I interferon in vivo.
Science
272:1947-1950[Abstract].
|
| 14.
|
Tough, D. F., and J. Sprent.
1994.
Turnover of naive- and memory-phenotype T cells.
J. Exp. Med.
179:1127-1135[Abstract/Free Full Text].
|
| 15.
|
Tripp, R. A.,
A. M. Hamilton-Easton,
R. D. Cardin,
P. Nguyen,
F. G. Behm,
D. L. Woodland,
P. C. Doherty, and M. A. Blackman.
1997.
Pathogenesis of an infectious mononucleosis-like disease induced by a murine -herpesvirus: role for a viral superantigen?
J. Exp. Med.
185:1641-1650[Abstract/Free Full Text].
|
| 16.
|
Usherwood, E. J.,
A. J. Ross,
D. J. Allen, and A. A. Nash.
1996.
Murine -herpesvirus-induced splenomegaly: a critical role for CD4 T cells.
J. Gen. Virol.
77:627-630[Abstract/Free Full Text].
|
| 17.
|
Usherwood, E. J.,
J. P. Stewart,
K. Robertson,
D. J. Allen, and A. A. Nash.
1996.
Absence of splenic latency in murine -herpesvirus 68-infected B cell-deficient mice.
J. Gen. Virol.
77:2819-2825[Abstract/Free Full Text].
|
| 18.
|
Weck, K. E.,
M. L. Barkon,
L. I. Yoo,
S. H. Speck, and H. W. Virgin.
1996.
Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68.
J. Virol.
70:6775-6780[Abstract/Free Full Text].
|
Journal of Virology, September 1999, p. 7866-7869, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Barton, E. S., Lutzke, M. L., Rochford, R., Virgin, H. W. IV
(2005). Alpha/Beta Interferons Regulate Murine Gammaherpesvirus Latent Gene Expression and Reactivation from Latency. J. Virol.
79: 14149-14160
[Abstract]
[Full Text]
-
Gangappa, S., Kapadia, S. B., Speck, S. H., Virgin, H. W. IV
(2002). Antibody to a Lytic Cycle Viral Protein Decreases Gammaherpesvirus Latency in B-Cell-Deficient Mice. J. Virol.
76: 11460-11468
[Abstract]
[Full Text]
-
Flano, E., Woodland, D. L., Blackman, M. A., Doherty, P. C.
(2001). Analysis of Virus-Specific CD4+ T Cells during Long-Term Gammaherpesvirus Infection. J. Virol.
75: 7744-7748
[Abstract]
[Full Text]
-
Belz, G. T., Doherty, P. C.
(2001). Virus-Specific and Bystander CD8+ T-Cell Proliferation in the Acute and Persistent Phases of a Gammaherpesvirus Infection. J. Virol.
75: 4435-4438
[Abstract]
[Full Text]
-
Kaur, A., Hale, C. L., Ramanujan, S., Jain, R. K., Johnson, R. P.
(2000). Differential Dynamics of CD4+ and CD8+ T-Lymphocyte Proliferation and Activation in Acute Simian Immunodeficiency Virus Infection. J. Virol.
74: 8413-8424
[Abstract]
[Full Text]
-
Sangster, M. Y., Topham, D. J., D'Costa, S., Cardin, R. D., Marion, T. N., Myers, L. K., Doherty, P. C.
(2000). Analysis of the Virus-Specific and Nonspecific B Cell Response to a Persistent B-Lymphotropic Gammaherpesvirus. J. Immunol.
164: 1820-1828
[Abstract]
[Full Text]
-
Gangappa, S., van Dyk, L. F., Jewett, T. J., Speck, S. H., Virgin, H. W. IV
(2002). Identification of the In Vivo Role of a Viral bcl-2. J. Exp. Med.
195: 931-940
[Abstract]
[Full Text]
Top
Abstract
Text
